Risk Factors for Survival and the Development of Hepatocellular Carcinoma in Patients with Primary Biliary Cirrhosis

被引:25
作者
Tomiyama, Yasuyuki [1 ]
Takenaka, Kazuyuki [2 ]
Kodama, Takahiro [2 ]
Kawanaka, Miwa [3 ]
Sasaki, Kyo [1 ]
Nishina, Sohji [1 ]
Yoshioka, Naoko [1 ]
Hara, Yuichi [1 ]
Hino, Keisuke [1 ]
机构
[1] Kawasaki Med Sch, Dept Hepatol & Pancreatol, Kawasaki, Kanagawa, Japan
[2] Yamaguchi Grand Med Ctr, Dept Gastroenterol & Hepatol, Yamaguchi, Japan
[3] Kawasaki Med Sch, Kawasaki Hosp, Dept Gen Internal Med 2, Kawasaki, Kanagawa, Japan
关键词
diabetes mellitus; liver fibrosis; prognosis; survival; ursodeoxycholic acid; BIOCHEMICAL RESPONSE; MEDICAL PROGRESS; CANCER-RISK; COHORT;
D O I
10.2169/internalmedicine.52.0010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Early diagnosis of hepatocellular carcinoma (HCC) is critical in the management of patients with primary biliary cirrhosis (PBC), since the prognosis of PBC has improved. The aim of this study was to investigate whether HCC development affects the prognosis of PBC and to identify the risk factors for HCC in Japanese patients with PBC. Methods We compared the survival rates between patients with HCC and those without and analyzed the risk factors for HCC development in 210 patients with PBC who were followed up for a median period of 8.5 years. Results HCC developed during follow-up in 11 patients (5.2%) and was diagnosed simultaneously at the time of diagnosis of PBC in five patients (2.4%) who were excluded from the analysis. A Kaplan-Meier analysis showed a significant difference in overall survival between the patients who did and did not develop HCC (p<0.001). A multivariate analysis revealed age (OR: 1.08, 95% confidence interval [CI]: 1.03-1.13, p=0.001), the albumin level (OR: 0.24, 95% CI: 0.10-0.56, p=0.001), the total bilirubin level (OR: 1.60, 95% CI: 1.09-2.36, p=0.017) and HCC development (OR: 2.97, 95% CI: 1.24-7.15, p=0.015) to be significant prognostic factors and identified only an advanced histological stage (Scheuer's classification III or IV, OR: 6.27, 95% CI: 1.80-21.83, p=0.004) to be a risk factor associated with HCC. Conclusion HCC development significantly affects the survival of patients with PBC, and an advanced histological stage is the only risk factor associated with HCC development. These results highlight the important role of liver fibrosis in hepatocarcinogenesis in patients with PBC.
引用
收藏
页码:1553 / 1559
页数:7
相关论文
共 22 条
  • [1] Caballería L, 2001, AM J GASTROENTEROL, V96, P1160
  • [2] Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
    Calle, EE
    Rodriguez, C
    Walker-Thurmond, K
    Thun, MJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) : 1625 - 1638
  • [3] Incidence, Risk Factors, and Survival of Hepatocellular Carcinoma in Primary Biliary Cirrhosis: Comparative Analysis from Two Centers
    Cavazza, Anna
    Caballeria, Llorenc
    Floreani, Annarosa
    Farinati, Fabio
    Bruguera, Miquel
    Caroli, Diego
    Pares, Albert
    [J]. HEPATOLOGY, 2009, 50 (04) : 1162 - 1168
  • [4] Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome
    Corpechot, Christophe
    Chazouilleres, Olivier
    Poupon, Raoul
    [J]. JOURNAL OF HEPATOLOGY, 2011, 55 (06) : 1361 - 1367
  • [5] Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
    El-Serag, HB
    Tran, T
    Everhart, JE
    [J]. GASTROENTEROLOGY, 2004, 126 (02) : 460 - 468
  • [6] The role of diabetes in hepatocellular carcinoma: A case-control study among United States veterans
    El-Serag, HB
    Richardson, PA
    Everhart, JE
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (08) : 2462 - 2467
  • [7] Hepatic and extrahepatic malignancies in primary biliary cirrhosis
    Floreani, A
    Baragiotta, A
    Baldo, V
    Menegon, T
    Farinati, F
    Naccarato, R
    [J]. HEPATOLOGY, 1999, 29 (05) : 1425 - 1428
  • [8] A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre
    Floreani, Annarosa
    Caroli, Diego
    Variola, Angela
    Rizzotto, Erik Rosa
    Antoniazzi, Sara
    Chiaramonte, Maria
    Cazzagon, Nora
    Brombin, Chiara
    Salmaso, Luigi
    Baldo, Vincenzo
    [J]. LIVER INTERNATIONAL, 2011, 31 (03) : 361 - 368
  • [9] Harada K, HEPATOLOGY IN PRESS
  • [10] Insulin Resistance and Metabolic Hepatocarcinogenesis with Parent-of-Origin Effects in A X B Mice
    Hines, Ian N.
    Hartwell, Hadley J.
    Feng, Yan
    Theve, Elizabeth J.
    Hall, Gregory A.
    Hashway, Sara
    Connolly, Jessica
    Fecteau, Michelle
    Fox, James G.
    Rogers, Arlin B.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2011, 179 (06) : 2855 - 2865